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In a retroviral rat model, we have investigated the nontransforming effects of murine leukemia virus FB29 on the bone
marrow. Upon intraperitoneal inoculation with murine leukemia virus FB29 of either neonatal or adult rats, bone marrow cells
became massively infected within the first 12 days postinoculation. In neonatally inoculated rats, a persistent productive bone
marrow infection was established, whereas in rats inoculated as adults, no infected bone marrow cells could be detected
beyond 12 days postinoculation. Retroviral infection was most likely cleared by an antiviral immune response (Hein et al.,
1995, Virology 211, 408–417). Exposure to virus irreversibly decreased numbers of bone marrow cells staining with
monoclonal antibody OX7 by 10–30%. Reduction of OX71 bone marrow cells by 20% was also observed in vitro, after bone
marrow cells from uninfected adult rats had been co-incubated with virus. FB29-envelope proteins were sufficient alone to
reduce numbers of OX71 bone marrow cells, both in vivo and in vitro. According to results on incorporation of propidium
iodide, decreased numbers of OX71 cells were due to cell death. By flow cytometric analyses OX71 bone marrow cells as
well as monocytes/macrophages were identified to be major target cells for infection with FB29 within the bone marrow.
Thus, the mechanism(s) responsible for death of OX71 bone marrow cells might be due to direct toxicity of viral envelope
proteins and/or to interactions of viral envelope proteins with cells of the monocytic lineage. © 1998 Academic Press
INTRODUCTION
Hematological abnormalities are frequently associ-
ated with viral infections (Young, 1993). Of the retroviri-
dae, Human Immunodeficiency Virus (HIV) (Re et al.,
1994), Simian Immunodeficiency Virus (SIV) (Mandell et
al., 1995; Watanabe et al., 1990), and Feline Immunode-
ficiency Virus (FIV) (Linenberger and Abkowitz, 1995)
cause bone marrow disorders with closely resembling
characteristics, i.e., peripheral blood cytopenias affect-
ing one or more hematopoietic lineages. This suggests
that the pathogenesis of the bone marrow suppression
associated with these lentiviruses is similar. Infections
with other retroviruses, e.g., Feline Leukemia Virus (Lin-
enberger and Abkowitz, 1995) or Murine Leukemia Virus
(MuLV) (Belli and Fan, 1994; Kabat, 1989), often result in
proliferative hematological disorders, although other de-
fects originating in the bone marrow have been de-
scribed (Linenberger and Abkowitz, 1995).
We recently described pathogenic effects of a Friend
MuLV, clone FB29, and of a variant, NT40, derived from
FB29, in Fisher rats (Czub et al., 1995). Both viruses as
well as the related clone PVC-211 (Masuda et al., 1992)
cause a progressive neurodegenerative disease in neo-
natally inoculated Fisher rats. However, neither Friend
virus nor the variants induced erythroleukemias in rats,
as they do in mice (Masuda et al., 1992; Sitbon et al.,
1986). As many MuLV-induced leukemias in mice depend
on infection of one or more hematopoietic lineages, the
bone marrow is a prime target for leukemogenic MuLV
(Dexter et al., 1977). It was therefore of interest to deter-
mine whether in rats MuLV failed to infect the bone
marrow.
In our previous study we observed a marked affinity of
both viruses, FB29 and NT40, for cells of the monocytic
lineage in rats (Czub et al., 1995). However, neither our
group nor another group was able to efficiently infect
macrophages with MuLV in vitro (Wong et al., 1989). For
the sheep lentivirus, visna, it has been suggested that
infection of macrophage precursors in the bone marrow
played an important role for dissemination of virus by
means of migration of infected monocytes into various
tissues (Gendelman et al., 1985). A similar mechanism
could have taken place in rats infected with FB29 or its
derivative NT40. Infection of rat macrophage precursors
before a postmitotic fixation occurred would provide a
suitable explanation for our previous findings of macro-
phage susceptibility for MuLV (Czub et al., 1995). There-
fore, we sought to identify whether rat macrophage pre-
cursors were susceptible for infection with MuLV.
Our results revealed that bone marrow cells (BMC)
were early and frequent targets for MuLV FB29 after
inoculation of both neonatal and adult Fisher rats. Within
the bone marrow, infection was clearly detected in Thy
11 cells—among which are early hematopoietic progen-
itor cells (van den Brink et al., 1991)—as well as in
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macrophages. After exposure to MuLV FB29, a Thy 11
subpopulation of rat BMC diminished irreversibly. As
FB29-envelope proteins alone were also sufficient to
reduce numbers of Thy 11 cells, suppression of Thy 11
BMC was not dependent on the addition of infectious
virus, excluding direct infection as an obligatory cause
for decreased Thy 11 cell numbers.
RESULTS
Rat BMC are early targets for MuLV FB29
Inoculation of neonatal Fisher rats with MuLV FB29
has been shown to result in persistent infection of sev-
eral organs such as blood, spleen, thymus, and central
nervous system (Czub et al., 1995). Here, we show by
means of a kinetic analysis that upon neonatal inocula-
tion of rats BMC became productively infected at around
6–8 days postinoculation (dpi). The number of produc-
tively infected BMC increased to levels of 1–10% of all
BMC producing virus [log 4.8 6 0.1 focus forming units
(FFU)/106 BMC; n 5 34; means 6 SE]. This occurred at
around 12–14 dpi and this proportion of infected BMC
was lifelong (Fig. 1).
Inoculation of adult Fisher rats with FB29 has previ-
ously been shown to result in an effective antiviral hu-
moral and cellular immune response (Hein et al., 1995).
In those animals, neither viremia nor productive infection
of spleen or thymus has been detected when analyzed at
or after 28 dpi (Hein et al., 1995). However, early after
inoculation of adult rats, BMC became massively in-
fected and in the first instance, i.e. up to 12 dpi, the
kinetics of BMC infection closely resembled that of neo-
natally inoculated rats (Fig. 1). At no time was viremia
detected (data not shown). After 12 dpi, a substantial
reduction of virally infected cells appeared to have oc-
curred, as productively infected cells could not be found
either in the bone marrow (Fig. 1) or in other organs of
animals inoculated as adults (Hein et al., 1995). It is likely
that the decline of virus-infected cells was due to the
emerging antiviral immune response. Despite the viral
clearance in this latter group of animals, rat BMC were
an early as well as a frequent target for MuLV FB29 in
both neonatal and adult Fisher rats.
FB29-infected OX71 as well as OX72/CD11b/c1 BMC
To identify and characterize BMC interacting with
FB29, flow cytometric analyses using cell-specific and
virus-specific immunolabeling were performed. In neo-
natally inoculated rats, around 12–31% (n 5 9) of all OX71
BMC was found to express viral antigens (Fig. 2A). The
number of double positive BMC remained at this level
throughout the lifetimes. In rats inoculated as adults, a
considerable proportion of OX71 BMC were also positive
for antiviral staining (4–12%, n 5 4; Fig. 2B) when ana-
lyzed before a substantial antiviral immune response
had developed. Of infected rats inoculated either as
neonates or adults, a considerable fraction of cells of the
monocytic lineage which were defined by expression of
CD11b/c (Robinson et al., 1986) could also be stained
with antiviral antibodies (10–45% in neonatally inoculated
animals, n 5 7, Fig. 2D; 4–18% in rats inoculated as
adults, n 5 4, Fig. 2E), indicating viral infection of bone
marrow-associated monocytes/macrophages. Viral tro-
pism for monocytes/macrophages of other organs has
been observed before in this animal model (Czub et al.,
1995). After 14 dpi, BMC expressing viral antigens could
not be found any longer in rats inoculated as adults.
Altogether, these findings correlated well with the results
of the infectious center assays (Fig. 1).
Decreased numbers of OX71 BMC in rats exposed to
MuLV FB29
To investigate possible consequences of the massive
bone marrow infection a flow cytometric analysis using
monoclonal antibody OX7 was performed. This antibody
stains many rat BMC including relatively primitive hema-
topoietic precursor cells (van den Brink et al., 1991). In
neonatally inoculated rats we observed a decline of
OX71 BMC, paralleling the spread of retroviral infection
in this organ (Figs. 1 and 3A). In these persistently in-
fected animals, numbers of OX71 BMC never recovered
to levels of uninfected age-matched control animals and
remained 22% below normal values (Fig. 3A). Similarly, in
rats inoculated as adults, numbers of OX71 BMC fell
below normal values at the time when BMC became
infected with FB29 and levelled out at 10% below num-
bers of OX71 BMC from uninfected controls (Fig. 3B).
Numbers of OX71 BMC in rats inoculated as adults never
reached levels of control animals again although—after
FIG. 1. Course of productive infection with MuLV FB29 in the bone
marrow upon intraperitoneal inoculation of neonatal (e) or adult ()
rats. Each symbol represents a titer from an individual animal deter-
mined by an infectious center assay.
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an antiviral immune response had been inaugurated—
virus-infected cells could not be detected in these rats
(Fig. 1). These results show that the cellular composition
of rat bone marrow was significantly modified upon ret-
roviral infection. Furthermore, it appears that the virus-
induced modification(s) on the cellular arrangement of
the bone marrow was irreversible, as viral clearance
from the bone marrow and from other organs did not lead
to restoration of OX71 BMC numbers to normal levels.
Histological analyses
Histological analyses of total bone marrow by means
of differential staining procedures revealed equal cellu-
FIG. 2. (A–F) Expression of viral proteins in rat BMC. BMC from rats inoculated as neonates (A,D) or adults (B,E) or from age-matched uninoculated
animals (C,F) were stained with monoclonal antibodies OX7 (A,B,C) and OX42 (D,E,F), respectively, and gated. Intracellular staining of viral proteins
is depicted on the y axis.
FIG. 3. A-C: Time course of numbers of OX71 rat BMC after inoculation of neonates either with MuLV FB29 (A) or with FB29 envelope proteins (C)
and of adult rats with MuLV FB29 (B), respectively. Numbers of OX71 rat BMC were determined by flow cytometry. Each symbol represents the ratio
of numbers of OX71 rat BMC from two individual animals: from one animal exposed to viral proteins to numbers of OX71 rat BMC from a second,
age-matched noninfected/nonexposed littermate.
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larity, normal architecture, and maturation of the ery-
throid, myeloid, and thromboid lineage in infected bone
marrow compared to that of normal animals (data not
shown). There was no increase in either storage iron or
fibrosis in infected bone marrow (data not shown). This
indicated that the actual process of Thy 11 cell number
reduction was difficult to visualize by histopathological
techniques and that apparent reactions of the host in
response to the decline of OX71 BMC did not occur.
Rapid decline of OX71 BMC after exposure to MuLV
FB29 in vitro
To further explore virus-induced bone marrow alter-
ations, BMC from uninfected adult rats (.5 weeks) were
incubated in vitro with FB29 (MOI 1) or with Mock-in-
fected cell culture supernatant and analyzed with regard
to the numbers of OX71 BMC at various timepoints
thereafter. Within 48 h of cultivation, numbers of OX71
BMC co-incubated with virus declined by 22% compared
to those of control BMC (Fig. 4A). Thus, in vitro cultivated
BMC responded to virus exposure in a manner similar to
BMC in vivo, indicating that the virus-induced suppres-
sion of OX71 BMC was an intrinsic feature of the bone
marrow and independent from, e.g., cellular influx from
other organs. Surprisingly, cocultivation of BMC with
FB29 resulted in only very limited productive infection of
BMC, i.e., log 2.4 6 0.2 FFU/106 BMC (n 5 5; means 6
SE).
FB29 envelope protein(s) induced reduction of OX71
BMC both in vivo and in vitro
As BMC hardly became infected in vitro, however,
numbers of OX71 BMC decreased upon viral exposure,
and we studied the effects of viral proteins alone. Previ-
ous investigations on the pathogenesis of MuLV-induced
diseases have pointed to viral envelope protein(s) play-
ing a major role in the disease processes (Hasenkrug et
al., 1996; Portis et al., 1990; Sitbon et al., 1986). We
constructed a FB29-envelope protein expression vector
(Fig. 5A) to test whether viral surface protein(s) alone
would be sufficient to reduce numbers of OX71 BMC.
Expression and secretion of FB29-envelope proteins into
supernatants of transfected 3T3 cells was controlled by
flowcytometric (Fig. 5B) and immunoblot (Fig. 5C) analy-
ses. Supernatants of transfected cells containing FB29
envelope proteins were administered intraperitoneally
(ip) into neonatal rats. Animals treated with envelope
proteins exhibited a reduced number of OX71 BMC com-
FIG. 4. A,B: Time course of numbers of OX71 rat BMC in vitro. BMC
were incubated with MuLV FB29 (A) or with FB29-envelope proteins (B).
Numbers of OX71 cells were determined by flow cytometry. Each
symbol represents the ratio of numbers of OX71 rat BMC exposed to
viral proteins to numbers of OX71 mock-treated cells (shown is a mean
of nine experiments).
FIG. 5. (A–C) Schematic diagram of a FB29-envelope gene expression vector, LTR-env-LTR(pBK) (A), and control of expression of FB29-envelope
proteins in 3T3 cells. Expression of FB29-envelope proteins on NIH3T3 cells transfected with LTR-env-LTR(pBK) was analyzed by flow cytometry.
Transfected (plain line) and nontransfected (dotted line) cells were stained with mAB 48 specific for gp70 of FB29 (B). Secretion of FB29-envelope
proteins from NIH3T3 cells either transfected with LTR-env-LTR(pBK) (env) or with a control vector LTR-GFP-LTR(pBK) (GFP) and of supernatants from
nontransfected cells was analyzed by immunoblotting (C).
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pared to numbers of BMC from animals treated with
control supernatants from untransfected cells (Fig. 3C).
The decline of OX71 BMC after treatment with envelope
proteins was not as strong as after inoculation of repli-
cation-competent virus into neonates; however, just like
in infected rats, numbers of OX71 BMC from rats treated
with envelope proteins remained below numbers of
OX71 BMC from control animals for life. Infectious virus
bearing an envelope protein reactive with mAb 48 was
never recovered from rats inoculated with viral proteins
(data not shown), excluding the possibilities of laboratory
contamination or generation of new viruses. In in vitro
experiments, FB29-envelope proteins also reduced num-
bers of OX71 BMC by up to 24% (Fig. 4B). These results
demonstrate that infection was not obligatory for the
induction of bone marrow alterations and that viral en-
velope proteins were sufficient to suppress numbers of
OX71 BMC.
Decline of OX71 BMC was due to cell death
If the decline of OX71 BMC was due to downregulation
of Thy 1 molecules from the cell surface, other cellular
surface markers on these cells might not be affected
after exposure to viral proteins. Therefore, we doubly
labeled BMC with mAb OX7 and with mAb OX22, the
latter staining 95% of OX71 BMC (data not shown). In
neonatally inoculated animals, numbers of OX71 and of
OX221 BMC declined in a similar manner, when stained
in parallel at various timepoints pi (Figs. 6A and 6B). This
suggested a loss of cells rather than a loss of cellular
surface marker Thy 1.
To determine whether OX71 BMC died upon expo-
sure to FB29-envelope proteins we analyzed BMC in
our in vitro system by means of propidium iodide (PI)
incorporation. Thirty hours post initial exposure, OX71
BMC exposed to viral envelope proteins incorporated
PI more frequently than OX71 BMC treated with con-
trol supernatants (Fig. 7). This tendency increased
with time (Fig. 7). These results demonstrate that ret-
roviral envelope proteins exhibited cytotoxic effects on
Thy 11 BMC from rats.
DISCUSSION
Many retroviruses can cause hematopoietic abnor-
malities, including HIV in humans (Maciejewski et al.,
1994; Re et al., 1994), SIV in monkeys (Mandell et al.,
1995; Watanabe et al., 1990), FIV in cats (Linenberger and
Abkowitz, 1995), and MuLV in mice (Li and Fan, 1990; Tse
et al., 1994). Here we report that retroviral infection of rats
also caused bone marrow alterations. In all of our exper-
imental approaches using MuLV FB29, we observed a
reduction of numbers of Thy 11 BMC, following very
closely viral replication and/or the presence of viral en-
velope proteins.
Both Thy 11 cells and monocytes/macrophages were
identified as major cellular targets within the bone mar-
row for FB29. The Thy 1 antigen, a glycoprotein of 25 kDa
(Letarte-Muirhead et al., 1975), is present on 25–40% of
rat BMC (Williams, 1976). Cells bearing this antigen rep-
resent immature hematopoietic cells, including pluripo-
tent stem cells (van den Brink et al., 1991). Both infection
and decline of Thy 11 BMC targeted only fractions of
these cells but not the entire population, indicating that a
subpopulation(s) with high susceptibility for infection
and/or alteration existed. Once Thy 11 subpopulations
receptive for infection, alteration, or both are defined
more precisely, it will be possible to show whether the
decline of Thy 11 BMC is due to direct interaction with
viral envelope proteins or to indirect mechanisms.
In addition to cells bearing the Thy 1 antigen, mono-
FIG. 7. Effects of FB29-envelope proteins on the viability of Thy 11
BMC in vitro. BMC were incubated with FB29-envelope proteins () or
with tissue culture supernatants from NIH3T3 cells transfected with
LTR-GFP-LTR (e). Thy 11 BMC were analyzed for their capacity to
incorporate propidium iodide (PI) at different timepoints. Each symbol
represents the ratio of Thy 11/PI1 BMC to Thy 11/PI2 BMC. With time,
Thy 11 BMC exposed to viral envelope proteins incorporated PI more
frequently than OX71 BMC treated with control supernatants. Shown is
a representative result of a total of three experiments.
FIG. 6. (A,B) Time course of numbers of OX71 (A) and of OX221 (B)
rat BMC after inoculation of neonates with MuLV FB29. Numbers of
OX71 and of OX221 rat BMC were determined by flow cytometry. Each
symbol represents the ratio of numbers of OX71 rat BMC from two
individual animals: from one infected animal to numbers from a second,
age-matched noninfected littermate. Of OX71 BMC 95% were also
positive for mAb OX22 (not shown).
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cytes/macrophages were found to be susceptible for
infection with FB29 within the bone marrow. Infection of
bone marrow resident monocytes/macrophages went
along without apparent modification of these cells. We
did not observe either macrophage hyperplasia or my-
eloid hyperplasia as described in bone marrows of mon-
keys early after SIV infection (Mandell et al., 1995). How-
ever, cells of the monocytic lineage often become acti-
vated upon retroviral infection, with the possible
consequence of damaging neighboring cells. For exam-
ple, HIV-induced bone marrow failure appears to be
related to TNF-a secretion by macrophages (Maciejew-
ski et al., 1994). Just like after infection with FB29, mac-
rophages are a major cellular target for HIV (McElrath et
al., 1989) as well as for SIV (Mandell et al., 1995). En-
hanced TNF-a production occurs upon exposure of mac-
rophages to HIV envelope proteins gp120/160 (Clouse et
al., 1991; Maciejewski et al., 1994; Riekmann et al., 1991).
Effects of enhanced TNF-a levels on BMC could be of an
inhibitory (Jacobsen et al., 1994) or a cytotoxic nature
(Bigda et al., 1994) or both. Similarly, numbers of Thy 11
BMC might have been reduced by an indirect mode of
actions mediated through monocytes/macrophages ac-
tivated by FB29-envelope proteins.
We would also expect pathological long-term conse-
quences of high levels of TNF-a. As such, differentiation
of the bone marrow could shift toward monocytes and
macrophages, as observed in vitro (Jacobsen et al., 1994;
Murphy et al., 1988). It would be interesting to find a
retroviral-induced TNF-a-mediated shift of hematopoietic
differentiation toward monocytes and macrophages in
vivo, too, because macrophagetropic viral variants might
take advantage of such a situation for enhanced viral
spread and subsequent further tissue damage, including
the bone marrow, in later stages of infection. This hy-
pothesis could also explain why we observed an even
more dramatic decline of Thy 11 BMC beginning at
40–50 days after FB29 infection or administration of
FB29-envelope proteins into neonatal animals.
Both in vivo and in vitro data revealed that FB29-
envelope proteins alone were sufficient to reduce num-
bers of Thy 11 BMC. Analyses based on PI incorporation
demonstrated that cell death was responsible for the
decline of numbers of OX71 BMC. It is thus likely that
FB29-envelope proteins are directly cytotoxic. Apart from
bone marrow suppression, cytotoxic effects of retroviral
envelope proteins might also be involved in other patho-
logical alterations, such as hemolytic anemia of mice
(Sitbon et al., 1986), neurodegeneration of both humans
and rodents (Hasenkrug et al., 1996; Lipton et al., 1991;
Portis et al., 1990; Toggas et al., 1994), and T-cell loss
during AIDS (Siliciano, 1996).
It has been suggested that antibodies directed against
HIV-envelope proteins are capable of inhibiting colony
formation by bone marrow progenitor cells derived from
AIDS patients (Donahue et al., 1987). An immune-medi-
ated mechanism might also play an important role in
Parvovirus-induced myeloid depression (Segovia et al.,
1995). We found no additional suppressive effects on
numbers of Thy 11 BMC after clearance of viral infection
from rats inoculated as adults. This indicates that elimi-
nation of virus-infected BMC by an antiviral immune
response was compensated well in these animals. Fur-
thermore, as the reduction of Thy 11 BMC was irrevers-
ible, clearance of viral infection did not have a beneficial
influence on the numbers of Thy 11 BMC. Therefore,
long-term consequences of reduced numbers of Thy 11
BMC might be equal in all animals exposed to virus or
viral envelope proteins—independently of their state of
infection and the antiviral immune response.
In summary, we describe a new bone marrow abnor-
mality induced by envelope proteins of Friend MuLV in
rats. As in susceptible mice, the rat bone marrow was
shown to be a major target organ for MuLV; however, it
does not give rise to leukemias. We further demonstrated
lifelong susceptibility of the rat bone marrow for at least
transient FB29 infection and associated alterations. This
contrasted with the situation for MuLV-induced leukemo-
genesis in AKR mice (Buckheit et al., 1987, 1988) and in
mice inoculated with Moloney MuLV (Belli and Fan,
1994), respectively. In both cases, early postnatal infec-
tion of the bone marrow with MuLV has been proposed
to be crucial for the development of leukemia in mice. It
also appeared that the reduction of numbers of Thy 11
BMC in rats very closely followed viral infection and/or
exposure to viral proteins but that the pathogenesis of
MuLV-induced leukemia in mice is composed of a rather
slow multistep process (Belli and Fan, 1994; Kabat, 1989;
Li and Fan, 1990). Thus, in the course of MuLV-induced
rat bone suppression quite different virus–host interac-
tions appear to be recruited than in the pathogenesis of
MuLV-induced leukemias in mice.
MATERIALS AND METHODS
Animals, inoculation, viruses, and infectious center
assay
Fisher rats were initially obtained from the Institut fu¨r
Versuchstierzucht (Hannover, Germany) and were bred
at our institute. Neonatal rats (0–24 hours postpartum)
were inoculated ip with 100-ml virus stock (containing
5.0 3 104–105 FFU; adult rats (.5 weeks) were inocu-
lated ip with 500-ml virus stock. For some experiments,
neonatal rats were inoculated with 100 ml of NIH3T3-cell
culture supernatant transfected with FB29-envelope
gene expression vector LTR-env-LTR(pBK) and with LTR-
GFP-LTR(pBK), respectively.
FB29 is a molecular clone of the I25 strain of Friend
MuLV (Sitbon et al., 1986). Neonatal inoculation of rats
with FB29 leads to infection of the brain, resulting in
spongiform neurodegeneration and mild neurological
signs (Hein et al., 1995). Infectivity of cell culture and of
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BMC was determined by means of a focal immunoassay
using monoclonal antibody (mAb) 48 specific for FB29
(Robertson et al., 1991), peroxidase-conjugated rabbit
anti-mouse immunoglobulin (Dako), and 3-amino-9-ethyl-
carbazol (Sigma) as described previously (Czub et al.,
1991).
Construction of a FB29-envelope gene expression
vector, LTR-env-LTR(pBK)
An envelope-LTR fragment (XbaI–PstI) from molecular
clone FB29 (Genbank Accession No. Z11128) encom-
passing nucleotides 5634–561 was cloned into pBKCMV
(Stratagene) from which the CMV promoter (SpeI–NheI)
had been excised before. A 59 LTR (ClaI–PstI) encom-
passing nucleotides 7702–561 from FB29 was placed
upstream of the envelope-LTR sequence in pBK. A neo-
mycin resistance gene outside retroviral vector se-
quences is driven by a SV40 promoter (Fig. 5A). A similar
procedure was chosen for construction of control vector
LTR-GFP-LTR(pBK) in which the envelope gene was re-
placed by the green fluorescent protein, GFP (Heim et al.,
1995). Plasmid DNA was transfected into NIH3T3 cells
using the calcium phosphate procedure (Graham and
van der Eb, 1973). Cells were cultivated in 10% FCS–
RPMI containing 800 mg/ml G418 (Gibco-BRL) to select
for stably transfected cell clones. Supernatants were
taken 2 weeks after withdrawal of G418 from the me-
dium.
Cultivation of BMC
BMC were obtained by flushing the marrow cavity with
phosphate-buffered saline (PBS). The cells were
washed, lysed with lysis buffer (0.155 M NH4Cl, 0.001 M
KH2CO3, 0.1 mM EDTA in H2O) for 4 min on ice, washed
again, and counted. A total of 5.0 3 105 BMC per well of
a TC12-plate (Nunc, Denmark) was seeded in 1.0 ml 10%
FCS–RPMI 1640 containing 72 mg/l penicillin, 120 mg/l
streptomycin, and 0.0028 M glutamine. Cells were incu-
bated for 24 h at 37°C in a humidified atmosphere
containing 5 vol.-% CO2. After 24 h, MuLV stock or cell
culture supernatant from either MOCK infected or trans-
fected cells was added to BMC cultures. At 12, 24, 36,
and 48 h after initial exposure, BMC were resuspended
by intensive pipetting and immunostained with mAb OX7
specific for Thy 1 (Mason and Williams, 1980) and phy-
coerythrin-conjugated goat anti-mouse immunoglobulin-
F(ab)-fragment (Dianova) as described previously (Hein
et al., 1995).
Flow cytometry analysis
NIH3T3 cells stably transfected with LTR-env-LTR(pBK)
or BMC were analyzed with a FACScan (Becton-Dickin-
son). A total of 2.0 3 105 cells were washed in FACS
buffer (0.1% bovine serum albumin 1 0.02% NaN3 in
PBS). BMC were stained with biotinylated mAb OX7 (Di-
anova), Texas Red 670-conjugated streptavidin (Gibco-
BRL), and with fluorescein isothiocyanate(FITC)-conju-
gated mAb OX42 specific for CD11b/c (Robinson et al.,
1986) or with mAB OX22 reacting with the high-molecu-
lar-weight forms of CD45 (Spickett et al., 1983). NIH3T3
cells stably transfected with LTR-env-LTR(pBK) were an-
alyzed with mAb 48 and phycoerythrin-conjugated goat
anti-mouse immunoglobulin G-F(ab)-fragment (Dianova).
Intracellular staining for virus proteins in BMC was per-
formed after staining of the cell surface. Cells were fixed
with formaldehyde (3.7%) for 30 min at room temperature,
permeabilized with Triton X-100 (0.3%) (Sigma) for 30 min
at room temperature, and stained intracellularly with
goat polyclonal antiserum directed against MuLV gp70
(kindly donated by R. Friedrich, Gieben) and FITC-conju-
gated rabbit anti-goat immunoglobulin G (Dako). Control
staining was performed with normal goat serum.
Propidium iodide staining
In some experiments, BMC were incubated with PI
(20 mg/ml) for 10 min at 4°C and analyzed by flow
cytometry to distinguish dead from live cells (Rados-
evic et al., 1990). Prior to PI incubation cells were
labeled with mAB OX7.
Immunoblot analysis
NIH3T3 cells were lysed in lysis buffer [4% sodium-
dodecyl-sulfate, 20% glycerin, 16.6 mM Tris (pH 6.8), and
4% b-mercaptoethanol] and boiled for 10 min. Superna-
tants of transfected or nontransfected cells were precip-
itated with trichloroacetic acid (final concentration 5%, 10
min on ice), pelleted (10 min, 5000g), washed with meth-
anol, dried, resuspended in equal volumes of PBS and
23 lysis buffer, and boiled for 10 min. A total of 10 ml of
the samples were subjected to electrophoresis in SDS–
polyacrylamide gel and subsequently transferred onto a
nitrocellulose filter. Nitrocellulose filters were blocked for
1 h at room temperature with PBS–Tween (0.1% bovine
serum albumin, 3% nonfat powdered milk, 0.5% Tween
20) and incubated overnight at 4°C with goat polyclonal
antiserum directed against MuLV gp70 (1/3000) and per-
oxidase-coupled rabbit anti-goat immunoglobulin G an-
tibodies (Dianova) (1/1000). Nitrocellulose filters were
washed twice in PBS–Tween for 10 min at room temper-
ature before relevation with the chemiluminiscence ECL
kit (Amersham Corp.) following the recommendations of
the manufacturer.
Histological examinations
Sections of 5 mm bone marrow were stained with H&E,
Giemsa, DiPAS, the Prussian blue iron stain, and the
Gomory silver staining method. By light microscopy, the
following parameters were evaluated: overall cellularity,
maturation in the myelopoiesis, erythropoiesis, thrombo-
poiesis, the medullary architecture, and the reticulin fiber
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content. The evaluation of the bone included the archi-
tecture of the spongiosa and the presence of osteoblasts
and osteoclasts on the surface.
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